Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

21-08-2018 | Brief Report

Brief Report: Maternal Opioid Prescription from Preconception Through Pregnancy and the Odds of Autism Spectrum Disorder and Autism Features in Children

Auteurs: Eric Rubenstein, Jessica C. Young, Lisa A. Croen, Carolyn DiGuiseppi, Nicole F. Dowling, Li-Ching Lee, Laura Schieve, Lisa D. Wiggins, Julie Daniels

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 1/2019

Abstract

Opioid use during pregnancy is associated with suboptimal pregnancy outcomes. Little is known about child neurodevelopmental outcomes. We examined associations between maternal opioid prescriptions preconception to delivery (peri-pregnancy) and child’s risk of ASD, developmental delay/disorder (DD) with no ASD features, or ASD/DD with autism features in the Study to Explore Early Development, a case-control study of neurodevelopment. Preconception opioid prescription was associated with 2.43 times the odds of ASD [95% confidence interval (CI) 0.99, 6.02] and 2.64 times the odds of ASD/DD with autism features (95% CI 1.10, 6.31) compared to mothers without prescriptions. Odds for ASD and ASD/DD were non-significantly elevated for first trimester prescriptions. Work exploring mechanisms and timing between peri-pregnancy opioid use and child neurodevelopment is needed.

vorige artikel Diagnostic and Therapeutic Misconception: Parental Expectations and Perspectives Regarding Genetic Testing for Developmental Disorders

volgende artikel Correction to: Brief Report: Maternal Opioid Prescription from Preconception Through Pregnancy and the Odds of Autism Spectrum Disorder and Autism Features in Children

Alleen toegankelijk voor geautoriseerde gebruikers

American Psychiatric Association. (2000). Diagnostic and statistcal manual of mental disoders (4). Arlington: American Psychiatric Publishing.

Bourgeron, T. (2015). From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nature Reviews: Neuroscience, 16(9), 551–563. https://doi.org/10.1038/nrn3992.CrossRefPubMed

Broussard, C. S., Rasmussen, S. A., Reefhuis, J., Friedman, J. M., Jann, M. W., Riehle-Colarusso, T., et al. (2011). Maternal treatment with opioid analgesics and risk for birth defects. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2010.12.039.CrossRefPubMed

Constantino, J. N. (2011). The quantitative nature of autistic social impairment. Pediatric Research. 69(5 Pt 2), 55R–62R, https://doi.org/10.1203/PDR.0b013e318212ec6e.CrossRefPubMedPubMedCentral

Desai, R. J., Hernandez-Diaz, S., Bateman, B. T., & Huybrechts, K. F. (2014). Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstetrics and Gynecology, 123(5), 997–1002. https://doi.org/10.1097/AOG.0000000000000208.CrossRefPubMedPubMedCentral

DiGuiseppi, C. G., Daniels, J. L., Fallin, D. M., Rosenberg, S. A., Schieve, L. A., Thomas, K. C., et al. (2016). Demographic profile of families and children in the Study to Explore Early Development (SEED): Case–control study of autism spectrum disorder. Disability and Health Journal, 9(3), 544–551. https://doi.org/10.1016/j.dhjo.2016.01.005.CrossRefPubMedPubMedCentral

Epstein, R. A., Bobo, W. V., Martin, P. R., Morrow, J. A., Wang, W., Chandrasekhar, R., et al. (2013). Increasing pregnancy-related use of prescribed opioid analgesics. Annals of Epidemiology, 23(8), 498–503. https://doi.org/10.1016/j.annepidem.2013.05.017.CrossRefPubMedPubMedCentral

Gonzalez-Nunez, V., Jimenez Gonzalez, A., Barreto-Valer, K., & Rodriguez, R. E. (2013). In vivo regulation of the mu opioid receptor: Role of the endogenous opioid agents. Molecular Medicine, 19, 7–17. https://doi.org/10.2119/molmed.2012.00318.CrossRefPubMedPubMedCentral

Kivisto, K., Tupola, S., & Kivitie-Kallio, S. (2015). Prenatally buprenorphine-exposed children: Health to 3 years of age. European Journal of Pediatrics, 174(11), 1525–1533. https://doi.org/10.1007/s00431-015-2562-0.CrossRefPubMed

Kocek, M., Wilcox, R., Crank, C., & Patra, K. (2016). Evaluation of the relationship between opioid exposure in extremely low birth weight infants in the neonatal intensive care unit and neurodevelopmental outcome at 2 years. Early Human Development, 92, 29–32. https://doi.org/10.1016/j.earlhumdev.2015.11.001.CrossRefPubMed

Lind, J. N., Interrante, J. D., Ailes, E. C., Gilboa, S. M., Khan, S., Frey, M. T., et al. (2017). Maternal use of opioids during pregnancy and congenital malformations: A systematic review. Pediatrics. https://doi.org/10.1542/peds.2016-4131.CrossRefPubMedPubMedCentral

Lord, C., Rutter, M., DiLavore, P. C., & Risi, S. (2012). Autism diagnostic observation schedule. Journal of Autism and Developmental Disorders. 30, 205–223CrossRef

Lyall, K., Croen, L., Daniels, J., Fallin, M. D., Ladd-Acosta, C., Lee, B. K., et al. (2017). The changing epidemiology of autism spectrum disorders. Annual Review of Public Health, 38, 81–102. https://doi.org/10.1146/annurev-publhealth-031816-044318.CrossRefPubMed

Norgaard, M., Nielsson, M. S., & Heide-Jorgensen, U. (2015). Birth and neonatal outcomes following opioid use in pregnancy: A Danish population-based study. Substance Abuse, 9(Suppl 2), 5–11. https://doi.org/10.4137/SART.S23547.CrossRefPubMed

Nygaard, E., Moe, V., Slinning, K., & Walhovd, K. B. (2015). Longitudinal cognitive development of children born to mothers with opioid and polysubstance use. Pediatric Research, 78(3), 330–335. https://doi.org/10.1038/pr.2015.95.CrossRefPubMedPubMedCentral

Pezalla, E. J., Rosen, D., Erensen, J. G., Haddox, J. D., & Mayne, T. J. (2017). Secular trends in opioid prescribing in the USA. Journal of Pain Research, 10, 383–387. https://doi.org/10.2147/JPR.S129553.CrossRefPubMedPubMedCentral

Reddy, U. M., Davis, J. M., Ren, Z., & Greene, M. F., Opioid Use in Pregnancy, N. A. S., & Childhood Outcomes Workshop Invited (2017). Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes: Executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation. Obstetrics and Gynecology, 130(1), 10–28. https://doi.org/10.1097/AOG.0000000000002054. S.CrossRefPubMedPubMedCentral

Ross, E. J., Graham, D. L., Money, K. M., & Stanwood, G. D. (2015). Developmental consequences of fetal exposure to drugs: What we know and what we still must learn. Neuropsychopharmacology, 40(1), 61–87. https://doi.org/10.1038/npp.2014.147.CrossRefPubMed

Rutter, M., Bailey, A., & Lord, C. (2003a). SCQ: Social Communication Questionnaire. Los Angeles: Western Psychological Services.

Rutter, M., Le Couteur, A., & Lord, C. (2003b). ADI-R: Autism Diagnostic Interview-Revised.

Sahley, T. L., & Panksepp, J. (1987). Brain opioids and autism: An updated analysis of possible linkages. Journal of Autism and Developmental Disorders, 17(2), 201–216. https://doi.org/10.1007/BF01495056.CrossRefPubMed

Schendel, D. E., Diguiseppi, C., Croen, L. A., Fallin, M. D., Reed, P. L., Schieve, L. A., et al. (2012). The Study to Explore Early Development (SEED): A multisite epidemiologic study of autism by the Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) network. Journal of Autism and Developmental Disorders, 42(10), 2121–2140. https://doi.org/10.1007/s10803-012-1461-8.CrossRefPubMedPubMedCentral

Sundelin Wahlsten, V., & Sarman, I. (2013). Neurobehavioural development of preschool-age children born to addicted mothers given opiate maintenance treatment with buprenorphine during pregnancy. Acta Paediatrica, 102(5), 544–549. https://doi.org/10.1111/apa.12210.CrossRefPubMed

Vuong, C., Van Uum, S. H., O’Dell, L. E., Lutfy, K., & Friedman, T. C. (2010). The effects of opioids and opioid analogs on animal and human endocrine systems. Endocrine Reviews, 31(1), 98–132. https://doi.org/10.1210/er.2009-0009.CrossRefPubMed

Whiteman, V. E., Salemi, J. L., Mogos, M. F., Cain, M. A., Aliyu, M. H., & Salihu, H. M. (2014). Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States. J Pregnancy. 2014, 906723, https://doi.org/10.1155/2014/906723.

Wiggins, L. D., Reynolds, A., Rice, C. E., Moody, E. J., Bernal, P., Blaskey, L., et al. (2015). Using standardized diagnostic instruments to classify children with autism in the study to explore early development. Journal of Autism and Developmental Disorders, 45(5), 1271–1280. https://doi.org/10.1007/s10803-014-2287-3.CrossRefPubMedPubMedCentral

Yazdy, M. M., Mitchell, A. A., Tinker, S. C., Parker, S. E., & Werler, M. M. (2013). Periconceptional use of opioids and the risk of neural tube defects. Obstetrics and Gynecology, 122(4), 838–844. https://doi.org/10.1097/AOG.0b013e3182a6643c.CrossRefPubMedPubMedCentral

Titel: Brief Report: Maternal Opioid Prescription from Preconception Through Pregnancy and the Odds of Autism Spectrum Disorder and Autism Features in Children
Auteurs: Eric Rubenstein
Jessica C. Young
Lisa A. Croen
Carolyn DiGuiseppi
Nicole F. Dowling
Li-Ching Lee
Laura Schieve
Lisa D. Wiggins
Julie Daniels
Publicatiedatum: 21-08-2018
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 1/2019
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-018-3721-8

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 1/2019

Higher Tactile Temporal Resolution as a Basis of Hypersensitivity in Individuals with Autism Spectrum Disorder

Applying Eye Tracking to Identify Autism Spectrum Disorder in Children

Sunk Cost Effect in Individuals with Autism Spectrum Disorder

Maternal Interactive Behaviours in Parenting Children with Williams Syndrome and Autism Spectrum Disorder: Relations with Emotional/Behavioural Problems

Movement Disorders and Syndromic Autism: A Systematic Review

The Influence of Noise on Autonomic Arousal and Cognitive Performance in Adolescents with Autism Spectrum Disorder